These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8419443)

  • 41. [General review of the value of hepatic MRI in the diagnosis and preoperative staging of liver metastasis from colon and rectum cancer].
    Borson O; Frering V; Gaillard C; Pellet O; Barral FG; Valette PJ
    Ann Chir; 1999; 53(5):397-405. PubMed ID: 10389329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
    Oudkerk M; van den Heuvel AG; Wielopolski PA; Schmitz PI; Borel Rinkes IH; Wiggers T
    Radiology; 1997 May; 203(2):449-56. PubMed ID: 9114103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of portal perfusion abnormalities: comparison of 3 ferucarbotran-enhanced magnetic resonance imaging sequences.
    Iwazawa J; Nishida N; Yamamoto A; Nango M; Ninoi T; Murakami Y; Nakamura K; Inoue Y
    J Comput Assist Tomogr; 2006; 30(2):165-72. PubMed ID: 16628027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of scanners and porto-scanners, both in helical mode, for the study of hepatic metastases. Prospective study in 12 patients].
    Vullierme MP; Abdelouafi A; Vilgrain V; Denys A; Sibert A; Menu Y
    Gastroenterol Clin Biol; 1997; 21(4):254-8. PubMed ID: 9207991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rim enhancement in colorectal metastases at CT during infusion hepatic arteriography. Does it represent liver parenchyma or live tumor cell zone?
    Irie T; Tsushima Y; Terahata S; Hatsuse K; Kusano S
    Acta Radiol; 1997 May; 38(3):416-21. PubMed ID: 9191433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CT done 4-6 hr after CT arterial portography: value in detecting hepatic tumors and differentiating from other hepatic perfusion defects.
    Nazarian LN; Wechsler RJ; Grady CK; Needleman L; Halpern EJ; Copit SE; Shapiro MJ; Rosato FE
    AJR Am J Roentgenol; 1994 Oct; 163(4):851-5. PubMed ID: 8092022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging.
    Hekimoglu K; Ustundag Y; Dusak A; Kalaycioglu B; Besir H; Engin H; Erdem O
    Eur J Radiol; 2011 Mar; 77(3):468-72. PubMed ID: 19781882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of spiral and non-spiral computed tomography arterial portography in the detection of potentially malignant liver masses.
    Young N; Sing T; Wong KP; Hollands M; Tait N
    J Gastroenterol Hepatol; 1997 May; 12(5):385-91. PubMed ID: 9195386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative segmental localization of hepatic metastases: utility of three-dimensional CT during arterial portography.
    Soyer P; Roche A; Gad M; Shapeero L; Breittmayer F; Elias D; Lasser P; Rougier P; Levesque M
    Radiology; 1991 Sep; 180(3):653-8. PubMed ID: 1871274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visceral metastases from melanoma: findings on MR imaging.
    Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
    AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and staging of chondromalacia patellae: relative efficacies of conventional MR imaging, MR arthrography, and CT arthrography.
    Gagliardi JA; Chung EM; Chandnani VP; Kesling KL; Christensen KP; Null RN; Radvany MG; Hansen MF
    AJR Am J Roentgenol; 1994 Sep; 163(3):629-36. PubMed ID: 8079858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
    Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
    Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging.
    Nomura K; Kadoya M; Ueda K; Fujinaga Y; Miwa S; Miyagawa S
    J Clin Gastroenterol; 2007 Sep; 41(8):789-95. PubMed ID: 17700429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
    Kasugai H; Katayama N; Sakai S; Yamakawa T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic lesion detection at MR imaging: a comparative study with four sequences.
    Blakeborough A; Ward J; Wilson D; Griffiths M; Kajiya Y; Guthrie JA; Robinson PJ
    Radiology; 1997 Jun; 203(3):759-65. PubMed ID: 9169701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of focal hepatic masses: STIR MR vs. CT during arterial portography.
    Paulson EK; Baker ME; Paine SS; Spritzer CE; Meyers WC
    J Comput Assist Tomogr; 1994; 18(4):581-7. PubMed ID: 8040443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is CT during arterial portography useful for the preoperative evaluation of liver metastases from pancreatic carcinoma?
    Furukawa H; Iwata R; Moriyama N
    Pancreas; 2001 Mar; 22(2):200-2. PubMed ID: 11249077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.